The FDA is revisiting its approval of azodicarbonamide, a chemical compound commonly found in commercially produced bread. This additive functions as a dough conditioner, creating a lighter and more pliable texture favored by many consumers and manufacturers. However, azodicarbonamide has faced scrutiny and bans in Europe and other regions due to studies suggesting potential links to respiratory issues and other health concerns.
The upcoming review by the FDA will involve a thorough examination of existing research, including recent findings on the chemical's potential effects. The agency aims to determine whether the current permissible levels of azodicarbonamide in food products remain safe for human consumption. Consumer advocacy groups have long urged the FDA to reconsider its stance, citing the precautionary principle and the availability of alternative dough conditioning methods.
The outcome of the FDA's review could have significant implications for the baking industry. If the agency decides to restrict or ban azodicarbonamide, manufacturers would need to reformulate their bread recipes, potentially impacting production costs and product characteristics. The review underscores the ongoing debate surrounding food additives and the balance between technological innovation and consumer safety.
FDA to Re-Evaluate Use of Azodicarbonamide in Bread
The Food and Drug Administration (FDA) announced it will review the safety of azodicarbonamide, a chemical used in some bread products in the United States. Azodicarbonamide is a dough conditioner that makes bread softer and more elastic. While approved for use in the U.S., it has been banned in Europe and other countries due to potential health concerns. The FDA's review will assess the latest scientific data to determine if the current regulations remain appropriate.
Source: Read the original article at CBS